What is β-Nicotinamide Mononucleotide - Global Market?
β-Nicotinamide Mononucleotide, often abbreviated as NMN, is a molecule that has garnered significant attention in the global market due to its potential health benefits. It is a precursor to NAD+ (nicotinamide adenine dinucleotide), a vital coenzyme found in all living cells that plays a crucial role in energy metabolism and maintaining cellular health. As people become more health-conscious and interested in longevity, the demand for NMN has surged. The global market for β-Nicotinamide Mononucleotide was valued at approximately US$ 255.3 million in 2023. This market is projected to grow significantly, reaching an estimated size of US$ 454.2 million by 2030, with a compound annual growth rate (CAGR) of 8.4% during the forecast period from 2024 to 2030. The market is dominated by a few key players, with the top three companies—GeneHarbor, Herbalmax, and Genex Formulas—holding about 74% of the market share. Geographically, the Asia-Pacific region is the largest market for NMN, accounting for approximately 70% of the global share, followed by the Americas with around 25%. This growth is driven by increasing consumer awareness and interest in health and wellness products that promote longevity and vitality.
in the β-Nicotinamide Mononucleotide - Global Market:
In the global market for β-Nicotinamide Mononucleotide, various types of NMN products are available to cater to the diverse needs of consumers. These products are primarily categorized based on their form, purity, and intended use. One of the most common forms of NMN available in the market is the powder form. This form is popular among consumers who prefer to incorporate NMN into their daily routines by mixing it with beverages or food. The powder form is often favored for its versatility and ease of use. Another prevalent form is NMN capsules or tablets, which are convenient for those who prefer a straightforward, no-fuss method of consumption. These capsules are typically standardized to contain a specific dosage of NMN, making it easier for consumers to monitor their intake. Additionally, some manufacturers offer NMN in liquid form, which is absorbed more quickly by the body and is ideal for individuals seeking rapid effects. The purity of NMN products is another critical factor that influences consumer choice. High-purity NMN is often preferred by health-conscious consumers who are concerned about the presence of impurities or additives. Manufacturers often highlight the purity levels of their products to attract discerning customers. Furthermore, NMN products are also differentiated based on their intended use. Some products are marketed specifically for their anti-aging benefits, targeting consumers interested in longevity and vitality. These products often emphasize their role in boosting NAD+ levels, which are associated with improved cellular health and energy metabolism. Other NMN products are designed for athletes and fitness enthusiasts, focusing on enhancing physical performance and recovery. These products may be combined with other supplements to provide a comprehensive solution for active individuals. Additionally, NMN is also used in skincare products, where it is touted for its potential to improve skin health and reduce the signs of aging. The diverse range of NMN products available in the market reflects the growing interest in this molecule and its potential benefits. As research continues to uncover more about NMN and its effects on health, it is likely that the variety of products will continue to expand, catering to an even broader audience.
Drug, Health Products, Cosmetic, Others in the β-Nicotinamide Mononucleotide - Global Market:
The usage of β-Nicotinamide Mononucleotide in various sectors such as drugs, health products, cosmetics, and others highlights its versatility and potential benefits. In the pharmaceutical industry, NMN is being explored for its potential therapeutic applications. Researchers are investigating its role in treating age-related diseases and conditions, given its ability to boost NAD+ levels, which decline with age. This decline is associated with various health issues, including metabolic disorders, neurodegenerative diseases, and cardiovascular problems. By replenishing NAD+ levels, NMN may help mitigate these conditions, making it a promising candidate for drug development. In the health products sector, NMN is widely used as a dietary supplement. Consumers are increasingly turning to NMN supplements to support their overall health and well-being. These supplements are marketed for their potential to enhance energy levels, improve cognitive function, and promote longevity. The growing interest in anti-aging and wellness products has fueled the demand for NMN supplements, as consumers seek natural solutions to maintain their health as they age. In the cosmetics industry, NMN is gaining popularity for its potential skin benefits. It is incorporated into skincare products for its purported ability to improve skin elasticity, reduce wrinkles, and enhance overall skin appearance. The anti-aging properties of NMN make it an attractive ingredient for cosmetic formulations aimed at consumers looking to maintain youthful and healthy skin. Additionally, NMN is also used in other sectors, such as animal health and agriculture. In animal health, NMN is being studied for its potential to improve the health and longevity of pets and livestock. In agriculture, it is being explored for its ability to enhance plant growth and resilience. The diverse applications of NMN across various industries underscore its potential as a versatile and valuable compound. As research continues to advance, it is likely that new and innovative uses for NMN will emerge, further expanding its presence in the global market.
β-Nicotinamide Mononucleotide - Global Market Outlook:
The global market for β-Nicotinamide Mononucleotide was valued at approximately US$ 255.3 million in 2023, and it is anticipated to grow to a revised size of US$ 454.2 million by 2030, reflecting a compound annual growth rate (CAGR) of 8.4% during the forecast period from 2024 to 2030. The market is primarily driven by a few key players, with the top three companies—GeneHarbor, Herbalmax, and Genex Formulas—collectively holding about 74% of the market share. This concentration of market power indicates a competitive landscape where these companies play a significant role in shaping market trends and innovations. Geographically, the Asia-Pacific region dominates the market, accounting for approximately 70% of the global share. This dominance can be attributed to the region's large population, increasing health awareness, and growing demand for wellness products. The Americas follow with a market share of around 25%, driven by a similar interest in health and longevity. The robust growth in the NMN market reflects the increasing consumer interest in products that promote health, wellness, and longevity. As more research highlights the potential benefits of NMN, its market presence is expected to expand further, attracting new players and innovations.
| Report Metric | Details |
| Report Name | β-Nicotinamide Mononucleotide - Market |
| Forecasted market size in 2030 | US$ 454.2 million |
| CAGR | 8.4% |
| Forecasted years | 2024 - 2030 |
| Segment by Purity: |
|
| Segment by Application |
|
| By Region |
|
| By Company | GeneHarbor, Quicksilver Scientific, Age Science, Herbalmax, Genex Formulas, Nutravita, Shinkowa Pharmaceutical, Oriental Yeast, Maac10 Formulas, EffePharm, Nutriop, Bontac, CELFULL, ChromaDex, Kingdomway |
| Forecast units | USD million in value |
| Report coverage | Revenue and volume forecast, company share, competitive landscape, growth factors and trends |
